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Figure 3: Ester Derivatives. Disk diffusion tests for esters vs. E. 
coli, S. aureus, and Mycobacterium show increased potency with 
increased chain length on Mycobacterium. Work completed by 
Phil Dietz and Dr. Morgan.
Abstract
In 2017, the World Health Organization reported that 10 
million people were infected with tuberculosis, 1.6 million of 
whom died. Tuberculosis is caused by a bacterium called 
Mycobacterium tuberculosis, which primarily infects an 
individual’s lungs. Unfortunately, failure to adhere to the long 
and arduous drug regimen has contributed to the emergence 
of antibiotic-resistant strains of M. tuberculosis. Therefore, 
the need for novel antibiotics is imperative to saving millions 
of lives. Our lab has recently developed a family of diphenyl 
ureas that exhibited increased antimicrobial activity toward 
Mycobacterium. Reported herein is the continuation of our 
previous research involving the synthesis of compounds with 
increased ester chain lengths and varying substituents on the 
phenyl ring. Compounds were confirmed using NMR 
spectroscopy and tested for antimicrobial activity using disk 
diffusion assays.
Conclusions
• 10 new urea derivatives were synthesized, 4 of which varied in 
chain length, and 6 of which varied in X groups and their 
positions on the phenyl ring.
• Without the ethyl amine group from the initial studies, little 
antimicrobial activity was observed.
Future Directions
• Synthesize compounds with both the ethyl amine and 
increasing ester chain lengths
• Retest the 30 compounds from the initial screening against 
Mycobacterium
• Examine a new class of compounds with charged side 
groups
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Previous Ester Modifications
Synthetic Routes
Background
• In 2017 alone, an estimated 10 million people were infected 
with tuberculosis. Of the 10 million infected people, 1.6 
million died.
• Tuberculosis is caused by a bacteria called Mycobacterium 
tuberculosis. It is transmitted through aerosol droplets and 
primarily affects the lungs.
• Current treatments for TB are long and arduous. Affected 
individuals are prescribed a six-month treatment involving 
isoniazid, rifampicin, pyrazinamide, and either ethambutol or 
streptomycin. 
• Failure to adhere to current drug treatments has led to 
antibiotic resistance. Multi-drug resistant (MDR), extensively-
drug resistant (XDR), and totally drug resistant (TDR) TB strains 
have been reported. 
Previous Research
• Previously made diphenyl ureas exhibit 
antimicrobial activity
• Analyzed with disk diffusion tests
Figure 1. Previous Data. Results of disk diffusion tests for 
diphenyl ureas. Tests were conducted by Kelsie Nauta. 
Biological Targets
By increasing the ester chain length and incorporating substituents 
from our previous study, we can develop a structure-activity 
relationship for these compounds. We hypothesize that these 
compounds will be more potent antibiotics against 
Mycobacterium.
Hypothesis
Proposed Targets
To test our hypothesis, we will synthesize molecules with 
increased ester chain lengths and different X groups attached to 
the phenyl ring.
Figure 4. Overall Synthesis. The 
complete three-step synthesis of the 
diphenyl urea compounds with varying R 
chain lengths and X groups. 
Biological Testing Results for Chain Length
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Figure 2. Biological targets for antibiotics.
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• Structures were confirmed by      
H-NMR and C-NMR analysis.
Disk Number Compound Zone of Inhibition (mm)
1 9.5
2 9.0
3 0.0
4 0.0
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Disk Number Compound Zone of Inhibition (mm)
5 9.0
6 9.5
7 0.0
8 DMSO 0.0
9 7.5
10 8.0
11 7.5
12 Oregano Oil 11.5
Figure 6. Biological Testing of Ester 
Length Compounds. The results of 
the disk diffusion test for the 
compounds with varying ester chain 
lengths showed little antimicrobial 
activity against Mycobacterium.  
Figure 7. Biological Testing of Various X Group Compounds.
DMSO was used as a negative control, and solution of diluted 
oregano oil was used as a positive control. The results of the disk 
diffusion test for the compounds with varying X group 
substituents showed little antimicrobial activity against 
Mycobacterium.  
Figure 5. Disk Diffusion Test. The concentration of the compound 
decreases as the distance from the disk increases. Therefore, a 
larger zone of inhibition indicates a more effective compound 
since it takes less of the compound to inhibit bacterial growth. 
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1. A lawn of bacteria is gently 
swabbed onto an agar plate. 
2. A disk that contains the 
desired compound is added to 
the plate. Multiple disks can 
be added to the same plate.
3. The agar plate is incubated for 
a few days, and the resulting 
zone of inhibition is 
measured.
Disk Diffusion Test
Biological Testing Results for X Groups
